BridgeMD
New treatment option for Obesity
Official title Non-invasive Brain Stimulation to Prepare the Patient for Bariatric Surgery (REBAS)
ClinicalTrials.gov ID: NCT06874309
What this study is testing
- What it's testing
- Obesity is a chronic metabolic condition characterized by excessive accumulation of body fat, which triggers physiological mechanisms that increase the risk of a wide range of health problems. The most effective treatment for severe obesity is metabolic-bariatric surgery, which can lead to a 15-20% weight reduction, significantly lowering the risks of illness and death.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- people with severe or morbid obesity (determined by BMI \> 35 or 40 kg/m2, respectively) eligible for BS treatment in compliance with the current...
- people who meet reduced control over eating behavior (disinhibition) criteria in the Eating Habits Questionnaire
You likely can't join if
- people unable to provide informed consent and those unable to understand and cooperate with study-related procedures (based on the physician's...
- people with a personal history of ischemic heart disease, myocardial infarction, stroke, heart failure, and atrial fibrillation
- people who have already undergone BS treatment in the past
- Pregnant people or people that plan on becoming pregnant during the study.
- people deemed unsuitable for the study based on expert evaluation (e.g., by a physician or neuropsychologist) will be excluded.
- people with dreadlocks (problematic for the EEG)
The study team makes the final eligibility decision.
Where it's taking place
- Brno, Czechia, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brno, Czechia, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.